TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Amber BioSciences AB
Closing information (x1000 EUR)
| Closing information | 2023/04 | 2022/04 | 2021/04 |
| Turnover |
12
|
12
|
10 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
5
|
4
|
1 |
| EBITDA |
5
|
4
|
2 |
| Total assets |
109
|
120
|
30 |
| Current assets |
26
|
30
|
28 |
| Current liabilities |
2
|
7
|
5 |
| Equity capital |
30
|
0
|
23 |
| - share capital |
9
|
0
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Solvency |
27.5%
|
0%
|
76.7% |
| Turnover per employee |
12
|
12
|
10 |
| Profit as a percentage of turnover |
41.7%
|
33.3%
|
10.0% |
| Return on assets (ROA) |
4.6%
|
3.3%
|
3.3% |
| Current ratio |
1300%
|
428.6%
|
560.0% |
| Return on equity (ROE) | 16.7% | 4.3% | |
| Change turnover |
1
|
1
|
-3 |
| Change turnover % |
13%
|
14%
|
-25% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.